Confirming And Notifying Death

NCT ID: NCT06910176

Last Updated: 2025-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-10

Study Completion Date

2025-12-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Most physicians are confronted with the death of patients during their practice, often as early as residency. It is their legal responsibility to certify a patient's death, as well as often to notify their loved ones.

Yet, these duties currently receive little or no specific training during the various cycles of medical education.

This task is not easy, however, and young professionals experience it with difficulty. Literature data show that residents are confronted with death late in their medical education and that they are insufficiently prepared when they have to perform their first death certificate. Indeed, residents report significantly correlated practical and emotional difficulties. These difficulties are notably linked to a feeling of lack of preparation through theoretical courses, a lack of familiarity with administrative procedures, and insufficient mastery of communicating with families. The highlighting of these difficulties and the desire for appropriate and respectful care for the deceased and their families, for whom the moment of announcement influences the experience of grief, call for an improvement in teaching on these topics. It is in this sense that the project was born to explore whether the creation of training, before their independent exposure to death and its announcement, i.e. at the end of the second cycle, was relevant. A prerequisite for this type of training project is indeed to question the acceptability of such an approach by students.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Death Records

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* DFASM3 student,
* At the Faculty of Medicine of Strasbourg, France, for the 2023-2024 academic year,
* Having taken the national ECOS (thus becoming an intern at the start of the following academic year in November 2024),
* Aged 18 years or older,
* Not opposed to participating in the study.
* Not having completed an internship in specialized palliative care facilities

Exclusion Criteria

* Refused to participate in the study.
* Not having taken the national ECOS.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de soins Palliatifs - CHU de Strasbourg - France

Strasbourg, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Catherine CHEVALIER-LAMOUILLE, MD

Role: CONTACT

33 3 88 11 65 86

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Catherine CHEVALIER-LAMOUILLE, MD

Role: primary

33 3 88 11 65 86

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9304

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.